ABT vs MAC · P/E 25, rev $44.33B vs rev $918.2M
Abbott Laboratories (ABT) versus Macerich Company (MAC) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Macerich Company (MAC) is a reit - retail company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported MAC revenue for 2024-12-31 was $918.2M. Net income was -$197.7M. Revenue was up 3.9% from 2023-12-31 to 2024-12-31. MAC currently screens at market cap $4.41B.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. MAC currently screens at market cap $4.41B.
Not investment advice. Open the ABT and MAC stock pages for the full models.
Not investment advice.